Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

11200	Companies
247841	Keywords
175596	Articles
133923	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

PRESS RELEASE

published on 09/05/2025 at 07:00, 1 year 1 month ago

Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
Newron Pharmaceuticals to present data on evenamide as add-on treatment for schizophrenia at 2025 WCBP. Focus on efficacy, safety, and mechanism of action. Landmark studies showcased

Clinical Program Schizophrenia Newron Pharmaceuticals Evenamide WCBP
BRIEF

published on 08/12/2025 at 07:05, 1 year 2 months ago

Newron Initiates Phase III ENIGMA-TRS Study for Treatment-Resistant Schizophrenia

Newron Pharmaceuticals Evenamide Schizophrenia Treatment Phase III Study TRS Therapy
BRIEF

published on 08/12/2025 at 07:05, 1 year 2 months ago

Newron lance l'étude de phase III ENIGMA-TRS pour la schizophrénie résistante au traitement

Newron Pharmaceuticals Evenamide Traitement De La Schizophrénie Étude De Phase III Thérapie TRS
PRESS RELEASE

published on 08/12/2025 at 07:00, 1 year 2 months ago

Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Newron Pharmaceuticals initiates Phase III ENIGMA-TRS program with evenamide as add-on therapy for treatment-resistant schizophrenia patients, targeting TRS population

Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS Program
BRIEF

published on 08/11/2025 at 07:05, 1 year 2 months ago

Newron Pharmaceuticals' Evenamide Shows Promise in Schizophrenia Treatment

Newron Pharmaceuticals Schizophrenia Treatment Evenamide Research Glutamate Modulation Neuropsychopharmacology Study
BRIEF

published on 08/11/2025 at 07:05, 1 year 2 months ago

L'Evenamide de Newron Pharmaceuticals s'avère prometteur dans le traitement de la schizophrénie

Newron Pharmaceuticals Traitement De La Schizophrénie Recherche Sur L'évenamide Modulation Du Glutamate Étude De Neuropsychopharmacologie
PRESS RELEASE

published on 08/11/2025 at 07:00, 1 year 2 months ago

Newron notes the publication of new preclinical research suggesting evenamide ameliorates schizophrenia-related dysfunction
Newron Pharmaceuticals notes new preclinical research indicating evenamide may improve schizophrenia-related dysfunction by targeting hippocampal pathology. Study shows potential for novel therapeutic strategy

Schizophrenia Newron Pharmaceuticals Evenamide Preclinical Research Hippocampus
BRIEF

published on 05/12/2025 at 07:05, 1 year 5 months ago

Newron's ENIGMA-TRS Phase III Program Approved for Treatment-Resistant Schizophrenia

Newron Pharmaceuticals Evenamide Phase III ENIGMA-TRS Treatment-resistant Schizophrenia Glutamatergic Modulation
BRIEF

published on 05/12/2025 at 07:05, 1 year 5 months ago

Le programme ENIGMA-TRS de phase III de Newron approuvé pour le traitement de la schizophrénie résistante au traitement

Newron Pharmaceuticals Evenamide Phase III ENIGMA-TRS Schizophrénie Résistante Au Traitement Modulation Glutamatergique
PRESS RELEASE

published on 05/12/2025 at 07:00, 1 year 5 months ago

Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Newron Pharmaceuticals announces approval for pivotal Phase III ENIGMA-TRS program evaluating evenamide as add-on therapy in treatment-resistant schizophrenia patients. Study results expected in Q4 2026

Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS Program

Accesswire

Published on 10/19/2026 at 14:30, 2 hours 36 minutes ago

Core Silver Intersects Copper Bearing VMS Mineralization at the Touleary Project
Published on 10/19/2026 at 14:00, 3 hours 6 minutes ago

Four Nines Gold Intersects 80.1 Meters Averaging 1.08 g/t Gold in Expanding Lower Telegraph Corridor at Hayden Hill
Published on 10/19/2026 at 13:30, 3 hours 36 minutes ago

Empress Announces Closing of Tongon Gold Stream Investment and Debt Financing
Published on 10/19/2026 at 13:30, 3 hours 36 minutes ago

Mako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albino
Published on 10/19/2026 at 13:01, 4 hours 5 minutes ago

CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States

View all ACCESSWIRE

EQS Group

Published on 10/19/2026 at 16:06, 59 minutes ago

EQS-Adhoc: Cherry SE: Revenue and adjusted EBITDA for the first nine months 2026 deviate from prior-year; additional financial support secured from majority shareholder
Published on 10/19/2026 at 16:05, 1 hour ago

Tomorrow.Mobility 2026 will gather over 240 international experts in its conferences
Published on 10/19/2026 at 15:55, 1 hour 10 minutes ago

"Feel your glo™": Artwork becomes fashion - Marcel Ostertag presents his exclusive fashion piece at the grand campaign finale in Hamburg
Published on 10/19/2026 at 15:50, 1 hour 15 minutes ago

Financial Street Forum's annual conference opens
Published on 10/19/2026 at 15:45, 1 hour 20 minutes ago

New Private Equity partners with ONE group solutions to build the data-driven fund governance platform for global asset managers

Les Echos

Published on 10/19/2026 at 11:45, 5 hours 20 minutes ago

Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 12 au 16 octobre 2026
Published on 10/19/2026 at 11:45, 5 hours 20 minutes ago

Guillemot Corporation S.A. | Weekly report share buyback from October 12 to October 16, 2026
Published on 10/19/2026 at 10:49, 6 hours 16 minutes ago

261019 BENETEAU Transactions sur actions propres
Published on 10/19/2026 at 08:15, 8 hours 51 minutes ago

Carrefour strengthens its leadership in convenience retail in France with the acquisition of Codifrance
Published on 10/19/2026 at 08:15, 8 hours 51 minutes ago

Carrefour renforce son leadership dans le commerce de proximité en France avec l’acquisition de Codifrance

View all LES ECHOS COMFI WIRE